An open label, randomised, pilot study of botulinum toxin type-A in the treatment of chronic tension-type headache

Mauro Porta, Giorgio Maggioni

Research output: Contribution to journalArticle

Abstract

The objective was to assess the effect of botulinum toxin type-A (BTX-A) in treating chronic tension-type headache (CTTH). A single centre, open label, pilot study was carried out at the Headache and Pain Center, Neurology Department, Policlinico San Marco, Bergamo, Italy and the Istituto Ortopedico Galeazzi, Milan, Italy. Sixty consecutive patients meeting accepted criteria for CTTH were randomised into 3 equal groups. Group 1: patients injected in fixed points; Group 2: patients injected using the "follow the pain" approach; and Group 3: as per Group 2 but combined with physiotherapy. Patients were assessed for 4 months using a headache diary, and efficacy was evaluated using a verbal rating scale (VRS), changes in headache frequency and drug intake count. At month 3, all groups showed improvements in VRS, mean headache frequency and mean drug intake, with Group 3 showing the greatest improvements in VRS and drug intake. BTX-A may be a promising therapy for treatment of CTTH using the "follow the pain" approach, especially when combined with adjunctive physiotherapy.

Original languageEnglish
Pages (from-to)251-255
Number of pages5
JournalJournal of Headache and Pain
Volume5
Issue number4
DOIs
Publication statusPublished - Dec 2004

Keywords

  • Botulinum toxin type-A
  • Neuromuscular
  • Pain
  • Physiotherapy
  • Tension-type headache

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Neuroscience(all)

Fingerprint Dive into the research topics of 'An open label, randomised, pilot study of botulinum toxin type-A in the treatment of chronic tension-type headache'. Together they form a unique fingerprint.

  • Cite this